ICU Leader Clinomic Secures €23M Series B Investment to Drive AI & Data Innovation in Critical Care
- Clinomic is harnessing AI and data-driven insights to redefine how healthcare professionals manage intensive care units. The Mona platform drives measurable improvements in clinical outcomes, operational efficiency, and cost savings for hospitals.
- Together with a private Family office, the DeepTech & Climate Fonds co-led the €23 million Series B.
- The financing will accelerate Clinomic’s expansion into international markets, enhance its AI / Data capabilities, and deepen its impact on critical care.
Aachen, Germany, 8th April 2025 – Clinomic, an emerging leader in medical technology, revolutionizing intensive care medicine through its cutting-edge AI-driven solutions, today announced the closing of a €23 million financing round co-led by DeepTech & Climate Fonds (DTCF) and a private family office. The funds will be used to expand the company’s presence in global markets and further develop its AI-powered healthcare solutions.
Founded in 2019 by intensive care physicians from RWTH Aachen University Hospital, Clinomic developed Mona, an integrated platform designed to streamline intensive care workflows. Mona records, organizes, analyzes, and visualizes patient and operational data, providing healthcare professionals with real-time insights to enhance decision-making—transforming intensive care to meet both human and technological standards for patients and medical workers.
Georg Griesemann, CEO of Clinomic, comments: “It is a great honor to have such strong partners on board who share our vision of transforming critical care. Their support enables us to accelerate our business even faster, especially in three key areas—expanding into international markets, further advancing our AI capabilities, and maximizing the potential of data to deliver life-saving impact.”
Günther Bogenrieder, Investment Manager at DTCF, adds: “From our very first conversations, we saw how Clinomic is using AI to solve critical healthcare challenges with real, measurable impact. Georg, Arne, Lukas, and their exceptional team are redefining intensive care. The Mona platform is significantly improving quality of patient care, while reducing healthcare costs by making all relevant data accessible in one platform and thus optimizing clinical and administrative workflows. These results prove that Clinomic is setting a new global standard for digital intensive care, and we’re proud to support their journey.”
Dr Arne Peine and Dr Lukas Martin, both Medical Doctors and Co-Founders explain: “As medical doctors working on the ICU, we experience it every day: Data density in high-acuity settings is increasing, leaving us less and less time for the patient. We need revolutionary new approaches to deliver optimal patient care. Good future care will only be possible if we close existing digitization gaps and consolidate all relevant data in one place. That’s why we’re building the ‘iPhone for the ICU’.”
Outlook and Future Plans by addressing Critical Care unmet needs
While suffering from a significant staff shortage, Intensive care units often face inefficient information management, leading to errors and financial strain. Clinomic’s Mona platform tackles these challenges by optimizing workflows, minimizing administrative tasks, and enabling better clinical decisions. Mona also supplies near real-time structured data, which accelerates medical research and fosters timely implementation of clinical insights. Through this holistic approach, Mona lays the groundwork for modernizing ICU care globally.
Looking ahead, Clinomic’s multi-revenue model – integrating hardware, software, and data services into the “iPhone for the ICU“ – fuels strong retention and scalability. By expanding Mona’s capabilities into all areas of high acuity care and launching its Health Data Lake to securely aggregate and analyze Intensive Care Medicine, Clinomic will enable seamless interoperability across healthcare systems. Already partnering with some of Europe’s largest hospitals, the company is striving to accelerate its footprint, delivering AI-driven benefits to large hospital chains, public and university hospitals, and regional facilities internationally.
About Clinomic
Clinomic is a medical technology startup founded by intensive care physicians from RWTH Aachen University Hospital. The company’s flagship solution, Mona, combines cutting-edge AI with advanced data analytics to streamline ICU workflows, reduce administrative burden, and improve patient outcomes. By integrating hardware, software, and data services into one platform, Clinomic is setting a new global standard for digital intensive care and driving the modernization of critical care medicine worldwide. www.clinomic.ai
About DeepTech & Climate Fonds
The DeepTech & Climate Fund (DTCF) invests up to €30 million in high-growth deep-tech and climate-tech companies in Germany and Europe. As an anchor investor and partner of long-term-oriented European investors, DTCF supports companies with extended development cycles and substantial financial needs in implementing sustainable growth strategies and actively contributes to expanding the technology ecosystem. Funded by resources from the German Future Fund and the ERP Special Fund, DTCF plans to invest up to €1 billion over the coming years to strengthen the European technology ecosystem. www.dtcf.de
Press Contacts
Clinomic Group GmbH
Georg Griesemann, CEO, press@clinomic.ai
DeepTech & Climate Fonds
Stephanie Stein, Head of Communications, s.stein@dtcf.de